Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Disappearing Markers for Daily Radiation Treatment Delivery

NCT07095114 is registered in ClinicalTrials.gov with Barbara Ann Karmanos Cancer Institute as lead sponsor.

NCT NCT07095114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07095114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Disappearing Markers for Daily Radiation Treatment Delivery
Lead sponsor
Barbara Ann Karmanos Cancer Institute
Phase
Not applicable
Overall status
Recruiting
Start date
August 18, 2025
Completion date
August 8, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ductal carcinoma in situ, stage i breast cancer, stage ii breast cancer, stage iii breast cancer